AXIOS January 30, 2024
Jacob Knutson

Elon Musk’s claim his brain-machine interface startup Neuralink implanted a device in its first live human subject comes after the company navigated a rigorous approval process, with some bumps along the way.

Why it matters: If successful, Neuralink says its technology will allow users to operate devices like a phone using only brainpower, and could be used to treat neurological diseases. While the technology is unproven, starting human testing is a major step.

Driving the news: Musk posted on X that the company’s first human subject received a brain implant on Sunday and was “recovering well.”

  • He claimed that initial results “show promising neuron spike detection,” referring to the device detecting the subject’s neural activity.
  • The announcement, which has...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Clinical Trials, Medical Devices, Patient / Consumer, Trends
Boston Scientific to acquire SoniVie for $540 million, expand hypertension treatment portfolio
Medicare Coverage Of Medical Technologies In A New Era
This year's top congressional medical technology priorities
Boston Scientific to acquire devicemaker: 3 things to know
Everything You Need To Know Before Getting An RFID Implant - 3

Share This Article